Literature DB >> 25546181

Evidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta-analysis and a systematic review of the literature.

Jayson Co1, Michael Benedict Mejia1, Janine Margarita Dizon1.   

Abstract

BACKGROUND: Current management of nasopharyngeal carcinoma (NPC) uses radiotherapy (RT) as the curative treatment modality. Radiation delivery techniques for NPC can be achieved using 2D conventional RT or intensity-modulated radiotherapy (IMRT).
METHODS: A systematic review and meta-analysis of the literature was undertaken to assess the effectiveness of IMRT versus 2D conventional RT in primary treatment of NPC.
RESULTS: IMRT showed better results than 2D conventional RT in terms of local control, regional control, and overall survival, but when stratified, only in T4, N2, and stage III were the differences that were seen. Objective saliva measurements and physician-graded xerostomia were better in IMRT. However, patient-reported xerostomia showed minimal improvement only in IMRT. The evidence of superiority of IMRT over 2D conventional RT is not clear.
CONCLUSION: In the absence of more clinical data demonstrating the superiority of IMRT in the treatment of nasopharyngeal carcinoma, 2D conventional RT seems to be a reasonable treatment option, especially in limited resource settings.
© 2015 Wiley Periodicals, Inc. Head Neck 38: E2130-E2142, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  2D radiotherapy; intensity-modulated radiotherapy; nasopharyngeal carcinoma (NPC); oncologic outcome; xerostomia

Mesh:

Year:  2015        PMID: 25546181     DOI: 10.1002/hed.23977

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  18 in total

1.  A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study.

Authors:  Chunxia Qin; Fang Liu; Jing Huang; Weiwei Ruan; Qingyao Liu; Yongkang Gai; Fan Hu; Dawei Jiang; Yu Hu; Kunyu Yang; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-20       Impact factor: 9.236

2.  Efficacy and safety of two different adjuvant chemotherapy regimens in combination with concurrent chemoradiotherapy in treating patients with advanced nasopharyngeal carcinoma: A protocol for randomized controlled trial.

Authors:  Lu-Lu Zhang; Jun Cui; Hong-Fei Tan; Zheng Xiao; Li-Xia Pan
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

3.  Chemotherapy use and survival in stage II nasopharyngeal carcinoma.

Authors:  Xin-Bin Pan; Shi-Ting Huang; Kai-Hua Chen; Xiao-Dong Zhu
Journal:  Oncotarget       Date:  2017-10-11

4.  Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method.

Authors:  Xueling Chen; Xiaodong Zhu; Zhongguo Liang; Ling Li; Song Qu; Kaihua Chen; Xinbin Pan
Journal:  Onco Targets Ther       Date:  2017-06-09       Impact factor: 4.147

5.  Which nasopharyngeal cancer patients need adaptive radiotherapy?

Authors:  Yu-Chang Hu; Kuo-Wang Tsai; Ching-Chih Lee; Nan-Jing Peng; Ju-Chun Chien; Hsin-Hui Tseng; Po-Chun Chen; Jin-Ching Lin; Wen-Shan Liu
Journal:  BMC Cancer       Date:  2018-12-10       Impact factor: 4.430

6.  Predictive factors of chemotherapy use in stage II nasopharyngeal carcinoma: A retrospective cohort study.

Authors:  Xin-Bin Pan; Shi-Ting Huang; Kai-Hua Chen; Yan-Ming Jiang; Xiao-Dong Zhu
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

7.  Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update.

Authors:  Ting Jin; Qun Zhang; Dong-Hua Luo; Feng Jiang; Qi-Feng Jin; Yuan-Yuan Chen; Xiao-Zhong Chen; Wei-Min Mao
Journal:  Transl Oncol       Date:  2019-11-16       Impact factor: 4.243

8.  Comparison of the efficacy between intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in stage II nasopharyngeal carcinoma.

Authors:  Xin-Bin Pan; Kai-Hua Chen; Shi-Ting Huang; Yan-Ming Jiang; Jia-Lin Ma; Zhong-Guo Liang; Song Qu; Ling Li; Long Chen; Xiao-Dong Zhu
Journal:  Oncotarget       Date:  2017-04-27

9.  Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.

Authors:  Xin-Bin Pan; Shi-Ting Huang; Kai-Hua Chen; Yan-Ming Jiang; Jia-Lin Ma; Song Qu; Ling Li; Long Chen; Xiao-Dong Zhu
Journal:  Oncotarget       Date:  2017-07-11

10.  Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.

Authors:  Bin Zhang; Feng Tao; Hao Zhang
Journal:  Mol Med Rep       Date:  2018-02-01       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.